Poland’s Medicalgorithmics is making a strategic leap into the UK healthcare market, marking a significant milestone in its global growth plans. The Warsaw-based company, which specialises in AI-driven diagnostics for cardiac conditions, has struck a deal with one of Britain’s largest private ECG and heart-rhythm monitoring providers. Under the agreement, Medicalgorithmics will deploy its proprietary DeepRhythmAI (DRAI) and DRP platforms to support real-time ECG analysis, following integration and regulatory clearance.

The pilot phase, which concludes either after three months or 500 paid ECG studies, will then transition into an indefinite long-term contract. If fully activated, the deal guarantees minimum annual revenues of approximately £83,448.

For the UK partner, the integration of DRAI (DeepRhythmAI, the AI brain that analyses heart rhythm data) and DRP (DeepRhythm Platform, the software platform that stores, organises, and displays the data) is expected to enhance workflow efficiency and throughput, particularly for ECG and Holter studies, offering faster interpretation and higher accuracy. 

From Medicalgorithmics’ point of view, the UK launch stands as a strong foothold in Western Europe, potentially paving the way for further expansion into other anglophone and continental markets.

Medicalgorithmics’ CEO Kris Siemionow said: “Securing a contract with a major partner who is committed to real-time, high-volume diagnostic solutions underlines the strength and attractiveness of our AI software. Our partner initially used a competitive product but chose to switch to our technology. We see increasing demand for our solutions, along with more client integrations and rising ECG session volumes handled by DRAI.”

The move comes amid a banner year for the company: since early 2025, it has inked 19 new contracts, surpassing its total for all of 2024. This surge reflects the firm’s strategic focus, adopted in June 2023 in collaboration with BioFund, on advanced AI algorithms and automated diagnostics.

As cardiac health monitoring shifts increasingly into remote and AI-enabled models, this partnership places Medicalgorithmics in a favourable position. The Polish firm’s ability to deliver real‐time, high-volume diagnostics aligns well with the trend toward tele-cardiology and digital health service models.

Source: ISBzdrowie

Photo: X @Bittium

Tomasz Modrzejewski